Context Therapeutics Inc (CNTX)
1.86
+0.01
(+0.54%)
USD |
NASDAQ |
Sep 27, 16:00
1.85
-0.01
(-0.54%)
After-Hours: 20:00
Context Therapeutics Free Cash Flow: -18.40M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.40M |
| March 31, 2024 | -19.68M |
| December 31, 2023 | -21.05M |
| September 30, 2023 | -17.75M |
| June 30, 2023 | -17.28M |
| March 31, 2023 | -15.46M |
| December 31, 2022 | -14.09M |
| September 30, 2022 | -15.12M |
| Date | Value |
|---|---|
| June 30, 2022 | -11.67M |
| March 31, 2022 | -11.19M |
| December 31, 2021 | -8.800M |
| September 30, 2021 | -4.014M |
| June 30, 2021 | -4.320M |
| March 31, 2021 | -2.562M |
| December 31, 2020 | -1.035M |
Free Cash Flow Range, Past 5 Years
-21.05M
Minimum
Dec 2023
-1.035M
Maximum
Dec 2020
-12.16M
Average
-14.09M
Median
Dec 2022
Free Cash Flow Benchmarks
| Collegium Pharmaceutical Inc | 275.62M |
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.356M |
| Cash from Financing (Quarterly) | 94.80M |
| Free Cash Flow Per Share (Quarterly) | -0.0611 |
| Free Cash Flow Yield | -38.48% |